HealthEquity director granted 2,877 RSUs
HEALTHEQUITY, INC. director Adrian T. Dillon received a grant of 2,877 shares of Common Stock on June 25, 2026 as a compensation award.
Rhea-AI Filing Summary
HEALTHEQUITY, INC. director Adrian T. Dillon received a grant of 2,877 shares of Common Stock on June 25, 2026 as a compensation award. The shares were granted at a price of $0.00 per share, increasing his directly held Common Stock to 62,395 shares after the transaction.
The grant represents restricted stock units, each equal to one share of common stock, that vest in full on the earlier of June 25, 2027 or the company’s next annual stockholder meeting in June 2027, with delivery of shares upon vesting. Dillon also holds several outstanding stock options to buy additional shares at exercise prices ranging from $32.50 to $66.06 with expirations between 2026 and 2030.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 2,877 shares
Grant/Award
6 txns
Insider
DILLON ADRIAN T
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 2,877 | $0.00 | $0.00 |
| holding | Stock Option (right to buy) | -- | -- | -- |
| holding | Stock Option (right to buy) | -- | -- | -- |
| holding | Stock Option (right to buy) | -- | -- | -- |
| holding | Stock Option (right to buy) | -- | -- | -- |
| holding | Stock Option (right to buy) | -- | -- | -- |
Holdings After Transaction:
Common Stock — 62,395 shares (Direct);
Stock Option (right to buy) — 24,446 contracts (Direct)
Footnotes (2)
- F1. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest in full on the earlier of; (i) June 25, 2027, or (ii) the date of the issuer's next annual stockholder meeting in June 2027. Vested shares will be delivered to the reporting person upon vesting.
- F2. The option is immediately exercisable.
Key Figures
Director stock grant: 2,877 shares
Post-grant holdings: 62,395 shares
RSU vesting date: June 25, 2027
+3 more
6 metrics
Director stock grant
2,877 shares
Common Stock awarded June 25, 2026 at $0.00
Post-grant holdings
62,395 shares
Common Stock directly held after award
RSU vesting date
June 25, 2027
Or earlier at next annual stockholder meeting in June 2027
Option at $66.06
4,012 underlying shares
Stock Option, expiration February 1, 2030
Option at $63.64
3,626 underlying shares
Stock Option, expiration February 1, 2029
Option at $32.50
7,632 underlying shares
Stock Option, expiration September 1, 2026
Key Terms
restricted stock unit, Stock Option (right to buy, grant/award acquisition, exercise price, +1 more
5 terms
restricted stock unit financial
"Each restricted stock unit represents a contingent right to receive one share"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
Stock Option (right to buy financial
"security_title": "Stock Option (right to buy)"
grant/award acquisition financial
"transaction_action": "grant/award acquisition""
exercise price financial
"exercisePrice": "66.0600""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
Common Stock financial
"underlying_security_title": "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did HealthEquity (HQY) director Adrian Dillon report in this Form 4?
Adrian Dillon reported receiving a grant of 2,877 shares of Common Stock on June 25, 2026. This award increased his directly held position to 62,395 shares, reflecting routine equity-based director compensation at HealthEquity.
What are the terms of Adrian Dillon’s restricted stock units at HealthEquity (HQY)?
Each restricted stock unit equals one share of HealthEquity common stock and vests in full on the earlier of June 25, 2027 or the company’s next annual stockholder meeting in June 2027, with vested shares delivered upon vesting.
What stock options does Adrian Dillon hold in HealthEquity (HQY) according to this filing?
The filing lists several stock options, including rights to buy 4,012 shares at $66.06, 3,626 shares at $63.64, 4,339 shares at $50.41, 4,837 shares at $46.40, and 7,632 shares at $32.50, expiring between 2026 and 2030.
Are Adrian Dillon’s HealthEquity (HQY) options currently exercisable?
A footnote states that the option is immediately exercisable. The filing also shows multiple outstanding stock option positions with specific exercise prices and expiration dates, indicating he can convert options into common shares if he chooses.
AI-generated analysis. How Rhea-AI works. Not financial advice.
